Comment
doi: 10.1136/bmj.39458.465845.3A.
Overprescribing PPIs: Time for a hospital antacid policy on Clostridium difficile
- PMID: 18202039
- PMCID: PMC2206281
- DOI: 10.1136/bmj.39458.465845.3A
Item in Clipboard
Comment
Overprescribing PPIs: Time for a hospital antacid policy on Clostridium difficile
BMJ.
.
No abstract available
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Overprescribing proton pump inhibitors.BMJ. 2008 Jan 5;336(7634):2-3. doi: 10.1136/bmj.39406.449456.BE. BMJ. 2008. PMID: 18174564 Free PMC article.
Similar articles
-
Acid suppression and the risk of Clostridium difficile infection.J Pediatr. 2013 Sep;163(3):627-30. doi: 10.1016/j.jpeds.2013.04.047. Epub 2013 Jun 5. J Pediatr. 2013. PMID: 23759424 Free PMC article. Review. No abstract available.
-
Deprescribing antacids after the diagnosis of Clostridioides difficile infection: A single-center observational study.J Infect Chemother. 2023 Feb;29(2):232-234. doi: 10.1016/j.jiac.2022.12.002. Epub 2022 Dec 9. J Infect Chemother. 2023. PMID: 36503067
-
Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection.Clin Infect Dis. 2021 Jun 15;72(12):e1084-e1089. doi: 10.1093/cid/ciaa1857. Clin Infect Dis. 2021. PMID: 33629099 Free PMC article.
-
Clostridium difficile infection associated with bismuth-based quadruple therapy (Pylera®) for Helicobacter pylori eradication.Gastroenterol Hepatol. 2019 Aug-Sep;42(7):459-460. doi: 10.1016/j.gastrohep.2019.01.012. Epub 2019 Mar 20. Gastroenterol Hepatol. 2019. PMID: 30902506 English, Spanish. No abstract available.
-
Risks versus benefits of long-term proton pump inhibitor therapy in the elderly.Geriatr Nurs. 2007 Jul-Aug;28(4):225-9. doi: 10.1016/j.gerinurse.2007.06.009. Geriatr Nurs. 2007. PMID: 17936957 Review. No abstract available.
Cited by
-
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children.Front Pharmacol. 2022 Feb 10;13:839972. doi: 10.3389/fphar.2022.839972. eCollection 2022. Front Pharmacol. 2022. PMID: 35222047 Free PMC article. Review.
-
Adverse Risks Associated With Proton Pump Inhibitors: A Systematic Review.Gastroenterol Hepatol (N Y). 2009 Oct;5(10):725-734. Gastroenterol Hepatol (N Y). 2009. PMID: 37967443 Free PMC article. Review.
-
Changing Clostridium difficile infection testing and treatment trends at a large tertiary care teaching hospital.Pharm World Sci. 2009 Oct;31(5):565. doi: 10.1007/s11096-009-9316-x. Epub 2009 Aug 6. Pharm World Sci. 2009. PMID: 19657721
-
Overutilization of proton-pump inhibitors: what the clinician needs to know.Therap Adv Gastroenterol. 2012 Jul;5(4):219-32. doi: 10.1177/1756283X12437358. Therap Adv Gastroenterol. 2012. PMID: 22778788 Free PMC article.
References
-
- Jump RL, Pultz MJ, Donskey CJ. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhoea? Antimicrob Agents Chemother 2007;51:2883-7. - PMC - PubMed
-
- Grube RR, May DB. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am J Health Syst Pharm 2007;64:1396-400. - PubMed
-
- Wohlt PD, Hansen LA, Fish JT. Inappropriate continuation of stress ulcer prophylactic therapy after discharge. Ann Pharmacother 2007;41:1611-6. - PubMed
-
- Scagliarini R, Magnani E, Pratico A, Bocchini R, Sambo P, Pazzi P. Inadequate use of acid-suppressive therapy in hospitalized patients and its implications for general practice. Dig Dis Sci 2005;50:2307-11. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
